Acumen Pharmaceuticals, Inc. (ABOS)
1.98
-0.08
(-3.88%)
USD |
NASDAQ |
Oct 23, 16:00
1.995
+0.02
(+0.76%)
After-Hours: 20:00
Acumen Pharmaceuticals Total Return Price : 1.98 for Oct. 23, 2026
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.98 |
| October 22, 2026 | 2.06 |
| October 21, 2026 | 2.03 |
| October 20, 2026 | 2.015 |
| October 19, 2026 | 1.77 |
| October 16, 2026 | 1.69 |
| October 15, 2026 | 1.67 |
| October 14, 2026 | 1.745 |
| October 13, 2026 | 1.815 |
| October 12, 2026 | 2.02 |
| October 09, 2026 | 2.14 |
| October 08, 2026 | 2.10 |
| October 07, 2026 | 2.10 |
| October 06, 2026 | 2.03 |
| October 05, 2026 | 2.13 |
| October 02, 2026 | 2.04 |
| October 01, 2026 | 2.07 |
| September 30, 2026 | 2.22 |
| September 29, 2026 | 2.245 |
| September 28, 2026 | 2.30 |
| September 25, 2026 | 2.24 |
| September 24, 2026 | 2.235 |
| September 23, 2026 | 2.305 |
| September 22, 2026 | 2.65 |
| September 21, 2026 | 2.59 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.65 |
| September 17, 2026 | 2.57 |
| September 16, 2026 | 2.61 |
| September 15, 2026 | 2.89 |
| September 14, 2026 | 2.79 |
| September 11, 2026 | 2.92 |
| September 10, 2026 | 2.86 |
| September 09, 2026 | 2.85 |
| September 08, 2026 | 3.16 |
| September 04, 2026 | 3.18 |
| September 03, 2026 | 3.09 |
| September 02, 2026 | 3.10 |
| September 01, 2026 | 2.92 |
| August 31, 2026 | 2.85 |
| August 28, 2026 | 2.92 |
| August 27, 2026 | 3.03 |
| August 26, 2026 | 2.99 |
| August 25, 2026 | 3.10 |
| August 24, 2026 | 3.075 |
| August 21, 2026 | 3.16 |
| August 20, 2026 | 3.19 |
| August 19, 2026 | 3.15 |
| August 18, 2026 | 2.74 |
| August 17, 2026 | 2.66 |
| August 14, 2026 | 2.67 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |